Adam Klauber is ranked #482 on 13Foresight, scored on hit rate, average return versus the market, and number of calls.

Adam Klauber

Q: How accurate are Adam Klauber's stock ratings?

About 59% of Adam's ratings were profitable over a one-year hold, with an average return of +10.8% per rating, measured by 13Foresight from historical prices.

William Blair

Wall Street Analyst

★★★★☆

#482

on 13Foresight · ranked by our own returns

60%

Success Rate

+10.7%

Average Return

49 of 82 calls profitable · +5.8% vs benchmark

Time Frame ⓘ

1 Yr 2 Yr 3 Yr 5 Yr

Compared To ⓘ

S&P 500 (SPY)

🔒 3-year track record is Pro. Showing 1-year — upgrade.

📈 Across the calls we could measure, roughly 60% of Adam Klauber's ratings turned a profit when each position was held for 1 year — averaging +10.7% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

91 Buy 61 Hold 8 Sell

Adam's Stock Coverage 41 ratings · 2026-08-14

Company	Date	Position	Consensus ⓘ	Price Target ⓘ	1-Yr Return	vs S&P 500 ⓘ
ARX Accelerant Holdings Class A	Aug 13, 2026	HOLD	Strong Buy +1.4% avg upside 12 analysts	—	·	·
AII American Integrity Insurance Group, Inc.	Aug 12, 2026	BUY	Strong Buy +9.0% avg upside 7 analysts	—	+4.7%	·
GCMG GCM Grosvenor	Aug 10, 2026	BUY	Strong Buy +10.4% avg upside 5 analysts	—	+0.3%	·
QNST Quinstreet	Aug 07, 2026	BUY	Strong Buy -14.7% avg upside 13 analysts	—	-2.8%	·
ALL Allstate	Aug 06, 2026	HOLD	Buy -14.2% avg upside 36 analysts	—	-5.0%	·
KMPR Kemper	Aug 06, 2026	SELL	Buy +143.5% avg upside 8 analysts	—	+8.9%	·
TWFG TWFG, Inc. Class A	Aug 06, 2026	BUY	Strong Buy +11.5% avg upside 8 analysts	—	-7.2%	·
HCI HCI Group	Aug 06, 2026	BUY	Strong Buy +8.0% avg upside 8 analysts	—	+1.9%	·
CRD.B Crawford & Company B	Aug 06, 2026	BUY	Buy +13.9% avg upside 3 analysts	—	+7.2%	·
SKWD Skyward Specialty Insurance Group, Inc.	Aug 05, 2026	BUY	Strong Buy +10.5% avg upside 15 analysts	—	-5.1%	·
PLMR Palomar Holdings	Aug 04, 2026	BUY	Strong Buy +14.1% avg upside 11 analysts	—	-5.8%	·
EHTH Ehealth	Aug 04, 2026	HOLD	Hold +1206.8% avg upside 19 analysts	—	-14.1%	·
LIFE Ethos Technologies Inc. Class A	Aug 04, 2026	BUY	Strong Buy -7.6% avg upside 12 analysts	—	+14.3%	·
BWIN Baldwin Insurance Group	Jul 31, 2026	BUY	Strong Buy +11.3% avg upside 15 analysts	—	+11.2%	·
AJG Arthur J Gallagher & Co	Jul 31, 2026	BUY	Strong Buy +10.1% avg upside 31 analysts	—	+1.6%	·
ERIE Erie Indemnity Company	Jul 31, 2026	BUY	Strong Buy 1 analyst	—	+5.7%	·
RYAN Ryan Specialty Group	Jul 31, 2026	BUY	Buy +21.5% avg upside 24 analysts	—	-5.0%	·
HIPO Hippo Holdings	Jul 31, 2026	HOLD	Buy -3.1% avg upside 9 analysts	—	+5.1%	·
WTW Willis Towers Watson	Jul 30, 2026	HOLD	Strong Buy +5.1% avg upside 28 analysts	—	-1.3%	·
MAX MediaAlpha	Jul 30, 2026	BUY	Strong Buy +34.7% avg upside 13 analysts	—	-2.7%	·
LMND Lemonade	Jul 29, 2026	HOLD	Hold -12.5% avg upside 22 analysts	—	+11.6%	·
AON Aon	Jul 29, 2026	BUY	Buy +3.2% avg upside 30 analysts	—	-5.4%	·
BRO Brown & Brown	Jul 28, 2026	HOLD	Buy +7.2% avg upside 25 analysts	—	-2.8%	·
KNSL Kinsale Capital Group	Jul 24, 2026	HOLD	Hold -3.0% avg upside 16 analysts	—	+8.6%	·
GSHD GooseHead Insurance	Jul 23, 2026	HOLD	Buy +11.5% avg upside 15 analysts	—	+23.0%	·
RLI RLI	Jul 23, 2026	HOLD	Buy +29.4% avg upside 14 analysts	—	+2.9%	·
CB Chubb	Jul 22, 2026	SELL	Buy -7.5% avg upside 33 analysts	—	-1.1%	·
MRSH Marsh & McLennan Companies	Jul 21, 2026	HOLD	Buy +1.4% avg upside 29 analysts	—	+6.1%	·
TRV Travelers Companies	Jul 17, 2026	HOLD	Hold -13.2% avg upside 33 analysts	—	+0.3%	·
PGR Progressive	Jul 15, 2026	HOLD	Buy +3.3% avg upside 29 analysts	—	+1.1%	·
PRMB Primo Brands	Jul 20, 2022	BUY	Strong Buy +5.3% avg upside 21 analysts	$18.00 27.33% Downside	+8.6%	·
AIG American International Group	May 05, 2020	HOLD	Buy +10.7% avg upside 33 analysts	—	+102.2%	·
FICO Fair Isaac	Mar 16, 2020	BUY	Strong Buy +42.3% avg upside 25 analysts	—	+99.4%	·
PRI Primerica	Feb 13, 2020	BUY	Buy -4.3% avg upside 12 analysts	—	+4.9%	·
RAMP LiveRamp Holdings	Aug 06, 2019	BUY	Buy +17.9% avg upside 13 analysts	—	+13.2%	·
MKL Markel	Mar 19, 2018	BUY	Buy -4.9% avg upside 10 analysts	—	-14.0%	·
CNO CNO Financial	Mar 12, 2018	BUY	Buy -34.3% avg upside 16 analysts	—	-24.2%	·
CRD.A Crawford & Company A	Mar 09, 2018	BUY	Strong Buy -9.5% avg upside 4 analysts	—	+33.0%	·
AMP Ameriprise Financial	Mar 02, 2017	BUY	Buy -10.8% avg upside 18 analysts	—	+17.3%	·
PRHI Presurance Holdings	Feb 23, 2016	HOLD	Sell -88.7% avg upside 4 analysts	—	·	·
CNA CNA Financial	Feb 09, 2015	HOLD	Sell -4.3% avg upside 4 analysts	—	-22.6%	·

🔒 36 more ratings — with price targets, crowd consensus and our measured returns.

Free account unlocks every analyst's full coverage table.

Adam Klauber — Frequently Asked Questions

How accurate are Adam Klauber's stock ratings?

Based on the calls 13Foresight could measure, about 59% of Adam's ratings were profitable over a one-year hold, with an average return of +10.8% per rating, or +6.0% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.

How is Adam ranked on 13Foresight?

Adam Klauber is currently ranked #482 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.

Which stocks does Adam cover?

Adam most recently has ratings on ARX, AII, GCMG, QNST, ALL, KMPR, TWFG, HCI, CRD.B, SKWD, PLMR, EHTH and 29 more. See the full coverage table above for positions, price targets and our measured returns.

Where can I see other analyst ratings?

Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.

Adam Klauber

Rating Distribution

Welcome to 13Foresight!